ArticleFrontiers in pharmacology2025
Assessing the adherence of large language models to clinical practice guidelines in Chinese medicine: a content analysis.
Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Integration of large language models and evidence-based Chinese medicine: A scoping review.Integrative medicine research · 2026Review
- Beyond transparency: why Traditional Chinese Medicine (TCM) need explainable artificial intelligence (XAI).Chinese medicine · 2026Review
- Comparative performance of ChatGPT and DeepSeek in interpreting the 2025 ESICM guidelines on sepsis fluid therapy.Digital healthArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: Whether large language models (LLMs) can effectively facilitate CM knowledge acquisition remains uncertain. This study aims to assess the adherence of LLMs to Clinical Practice Guidelines (CPGs) in CM. Methods: This cross-sectional study randomly selected ten CPGs in CM and constructed 150 questions across three categories: medication based on differential diagnosis (MDD), specific prescription consultation (SPC), and CM theory analysis (CTA). Eight LLMs (GPT-4o, Claude-3.5 Sonnet, Moonshot-v1, ChatGLM-4, DeepSeek-v3, DeepSeek-r1, Claude-4 sonnet, and Claude-4 sonnet thinking) were evaluated using both English and Chinese queries. The main evaluation metrics included accuracy, readability, and use of safety disclaimers. Results: Overall, DeepSeek-v3 and DeepSeek-r1 demonstrated superior performance in both English (median 5.00, interquartile range (IQR) 4.00-5.00 vs. median 5.00, IQR 3.70-5.00) and Chinese (both median 5.00, IQR 4.30-5.00), significantly outperforming all other models. All models achieved significantly higher accuracy in Chinese versus English responses (all p < 0.05). Significant variations in accuracy were observed across the categories of questions, with MDD and SPC questions presenting more challenges than CTA questions. English responses had lower readability (mean flesch reading ease score 32.7) compared to Chinese responses. Moonshot-v1 provided the highest rate of safety disclaimers (98.7% English, 100% Chinese). Conclusion: LLMs showed varying degrees of potential for acquiring CM knowledge. The performance of DeepSeek-v3 and DeepSeek-r1 is satisfactory. Optimizing LLMs to become effective tools for disseminating CM information is an important direction for future development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.